Biological Background and Function of GGA2

GGA2 (Golgi-associated, gamma-adaptin ear-containing, ARF-binding protein 2) is a member of the GGA family of monomeric clathrin adaptor proteins, which includes GGA1, GGA2, and GGA3. These proteins are highly conserved across eukaryotes and play indispensable roles in the regulated sorting of transmembrane cargo proteins from the trans-Golgi network (TGN) to endosomes and lysosomes.

GGA2 contains four functionally distinct domains: an N-terminal VHS (Vps27/Hrs/STAM) domain that recognizes dileucine-based and acidic cluster-dileucine sorting motifs on cargo proteins such as mannose-6-phosphate receptors (MPRs); a GAT (GGA and Tom1) domain that binds activated ARF GTPases (particularly ARF1) and ubiquitinated cargo; a hinge region that interacts with clathrin heavy chain; and a C-terminal GAE (gamma-adaptin ear) domain that recruits accessory proteins to sites of vesicle budding.

Through these domain interactions, GGA2 coordinates the selective incorporation of lysosomal enzymes and other cargo into clathrin-coated vesicles at the TGN, ensuring faithful delivery to the endolysosomal compartment. Dysregulation of GGA2-mediated trafficking has been implicated in lysosomal storage disorders, Alzheimer's disease-related BACE1 trafficking, and cancer cell invasiveness, making it an important target for mechanistic cell biology research.

Protein Specifications and Quality Attributes

Recombinant Human GGA2 Protein (SKU: rp375969) is produced recombinantly to support biochemical and cell biology research applications. When evaluating any recombinant protein reagent, researchers should confirm the following key quality parameters with the product datasheet:

• Expression system: The host expression system (e.g., E. coli, insect, or mammalian) influences post-translational modification status and should be selected according to experimental requirements.
• Purity: Purity should typically be ≥85% as assessed by SDS-PAGE for use in binding assays and biochemical experiments. Confirm the exact purity specification on the current certificate of analysis (CoA).
• Formulation: The buffer composition, presence of carrier proteins (e.g., BSA), and glycerol content affect protein stability during storage and experimental compatibility.
• Molecular weight: Confirm the expected molecular weight, including any affinity tags, from the product datasheet to correctly interpret SDS-PAGE and Western blot results.
• Endotoxin level: For cell-based assays, low endotoxin specification is critical; verify the endotoxin value on the CoA.

Always refer to the current Aladdin Scientific product page for rp375969 and the accompanying CoA for lot-specific verified specifications.

Reconstitution and Handling Protocol

Proper reconstitution and handling of Recombinant Human GGA2 Protein are essential to preserve activity and reproducibility. Follow the guidelines below as a general framework, and always consult the product-specific datasheet for authoritative instructions:

1. Equilibration: Allow the vial to equilibrate to room temperature for approximately 5–10 minutes before opening. Do not reconstitute a frozen protein directly.
2. Reconstitution: Centrifuge the vial briefly (1,000 × g, 30 seconds) before opening to collect lyophilized material. Reconstitute in the recommended volume of sterile, deionized water or the buffer specified on the datasheet. Gently pipette to mix; do not vortex.
3. Working concentration: Prepare aliquots at working concentrations appropriate for your assay to minimize freeze-thaw cycles. Carrier protein (0.1% BSA) may be added to improve stability in dilute solutions.
4. Storage after reconstitution: Store short-term at 4°C (up to 1 week) or long-term at -80°C in single-use aliquots. Avoid repeated freeze-thaw cycles, which can cause aggregation and loss of activity.
5. Sterility and contamination control: Perform reconstitution under aseptic conditions if the protein is to be used in cell-based assays.

Note: Specific reconstitution volumes, buffer compositions, and stability data are provided in the lot-specific CoA for rp375969. Always refer to that document for definitive handling instructions.

Research Applications and Experimental Considerations

Recombinant Human GGA2 Protein is suited for a range of in vitro research applications in cell biology and biochemistry:

• Protein-protein interaction studies: The VHS and GAT domains of GGA2 provide well-defined binding interfaces for studying interactions with ARF1, ubiquitinated cargo, and sorting motif-containing peptides using pull-down, co-immunoprecipitation (co-IP), and surface plasmon resonance (SPR) assays.
• Biochemical reconstitution: Purified GGA2 can be used in in vitro reconstitution experiments to study clathrin coat assembly and cargo sorting at model TGN membranes.
• Antibody validation and Western blot standards: Recombinant GGA2 serves as a positive control antigen for validating anti-GGA2 antibodies in Western blotting and ELISA formats.
• Structural biology: Purified recombinant protein may support crystallography or cryo-EM studies aimed at resolving domain-specific interaction interfaces.
• Drug target research: Given GGA2's involvement in BACE1 and MPR trafficking, it is a relevant reagent for identifying small-molecule modulators of TGN sorting pathways relevant to neurodegeneration and lysosomal disease.

Experimental tip: Because GGA2 activity depends on ARF GTPase binding, experiments assessing functional activity should include appropriate ARF1·GTP controls. Confirm assay compatibility with the specific formulation of rp375969 using the CoA before designing downstream experiments.